Baricitinib for Previously Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Ren, S. orcid.org/0000-0003-3568-7124, Bermejo, I., Simpson, E. et al. (4 more authors) (2018) Baricitinib for Previously Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. ISSN 1170-7690

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Dates:
  • Accepted: 18 January 2018
  • Published (online): 3 March 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 30 Jan 2018 10:49
Last Modified: 16 Mar 2018 13:22
Published Version: https://doi.org/10.1007/s40273-018-0616-7
Status: Published online
Publisher: Adis
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-018-0616-7

Share / Export

Statistics